Results 261 to 270 of about 338,185 (301)

Secondary infection in severe COVID-19 patients: clinical and microbial patterns at a tertiary hospital in Vietnam. [PDF]

BMC Infect Dis
Anh PH, Vinh C, Lan NPH, Minh HQ, Ngan LTQ, Thao HP, Nguyen MTS, Dung NT, Jeon Y, Park SE, Duy PT.   +10 more
europepmc   +1 more source

Impact of COVID-19 on new pharmacotherapy for insomnia: A matched cohort study using the national insurance claims database in Japan. [PDF]

PLoS One
Miyamori D, Yoshida S, Omori W, Kashima S, Ito M.   +4 more
europepmc   +1 more source

Evaluation of the cardiopulmonary effects of repurposed COVID-19 therapeutics in healthy rats. [PDF]

Sci Rep
Ozhan O, Yildiz A, Bakar B, Ulu A, Kucukakcali Z, Karaca E, Vardi N, Ates B, Parlakpinar H.   +8 more
europepmc   +1 more source

Artemether-lumefantrine versus pyronaridine-artesunate for the treatment of malaria in patients with mild to moderate COVID-19 in Kenya and Burkina Faso: a randomised open-label trial (MALCOV). [PDF]

EClinicalMedicine
Tangara B, Barsosio HC, Marlais T, Kabore JMT, Tiono AB, Otieno K, Wanjiku M, Achieng M, Onyango ED, Ondieki ED, Aura H, Odawo T, Allen DJ, Hannan L, Tetteh KK, Soulama I, Ouedraogo A, Serme SS, Soulama BI, Barry A, Badoum ES, Matthewman J, Brazal-Monzó H, Canizales J, Drabko A, Wu W, Kariuki S, Lesosky M, Sirima SB, Drakeley C, Ter Kuile FO.   +30 more
europepmc   +1 more source